Latest Drug Safety Monitoring News

Page 1 of 1

Dimerix’s DMX-200 Trial Clears Sixth Safety Review, Advancing Hope for FSGS Patients

Dimerix Limited’s ACTION3 Phase 3 trial for DMX-200 in treating FSGS kidney disease has passed its sixth independent safety review with no concerns, reinforcing the drug’s promising safety profile.

Ada Torres

22 May 2025

Top